ARCHIVES

NIH Probing: Double Dipping” Allegation

This article is from The Cancer Letter archive.

Vol. 07 No. 36 | September 4, 1981

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Expanded Tissue Resources, Equipment Funds Planned.

December 8, 2000

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014